EMG
OXFD

Ellington Management Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Ellington Management Group’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-15,900
Closed -$198K – 971
2018
Q1 		$198K Buy
+15,900
New +$194K 0.01% 743

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Ellington Management Group's OXFD Position: Q2 2018 in Review

Ellington Management Group sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2018, closing a stake of 15,900 shares — an estimated $198K sold.

Ellington Management Group first reported a position in OXFD in Q1 2018 and held it in 1 quarter. The position peaked at $198K in Q1 2018. 77 funds tracked by Wall St. Rank hold OXFD as of Q2 2018.

  • Ellington Management Group reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2018 after selling out during the quarter.
  • Ellington Management Group sold 15,900 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2018, an estimated $198K.
  • Ellington Management Group first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2018 and held it in 1 quarter.
  • Ellington Management Group's Oxford Immunotec Global PLC Ordinary Shares position peaked at $198K in Q1 2018.
  • 77 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2018.

Based on Ellington Management Group's 13F filing for Q2 2018, filed 14 Aug 2018.